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Scheme S1: Synthesis of (A) the Ga-NOTA complex and (B) the dendrimers 1 and Ga-
1. 
     
  
4 
 
Figure S1: (A) 1H- and (B) 13C-NMR spectra of the NOTA-conjugated dendrimer 1 
compared to the amine-terminated dendrimer recorded in D2O at 300K. (C) HSQC 
characterization of NOTA-conjugated dendrimer 1, and (D) the enlarged region of the 
HSQC spectrum in (C). 
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Figure S2: ESI-HRMS spectrum of (A) 1 and (B) [69Ga]Ga-1 recorded in acidified 
methanol.  
A  
 
B  
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Figure S3：The [69Ga]Ga-1 nanosystem is stable with similar size up to one week. 
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Figure S4: (A) Representative radio instant thin-layer chromatogram (radio-iTLC) of 
[68Ga]Ga-1 without further purification (developing agent: sodium citrate 0.10 M pH = 
5.0). (B) Analysis of the radiochemical stability by radio-iTLC of [68Ga]Ga-1 in 0.9% 
NaCl solution and in human serum at room temperature and at 37°C.  
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Figure S5: Blood clearance of [68Ga]Ga-1 in orthotopic SOJ6-xenograft mice 5, 10, 20, 
30, 60 and 90 minutes after intravenous injection. Decay-corrected blood fraction is 
represented as mean ± SD percentage injected dose per gram for each time point (n = 3 
mice). 
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Figure S6: Cytokine inducement of 1 and [69Ga]Ga-1 at different doses. 1×, 5× and 
10× means the formulations were administered at the dose equal to the PET-imaging 
dose, 5 times the imaging dose and 10 times the imaging dose, respectively. LPS 
(lipopolysaccharides), a positive control, was administered via intraperitoneal injection 
at the dose of 5.0 mg/kg. Blood was withdrawn at 3.0 h and 24 h post administration. 
Concentrations of TNF-α, IFN-γ, IL-6, CXCL1 (KC), MCP-1, GM-CSF, IL-1 and IL-
5 were measured with Luminex-based technology. Data revealed that LPS triggered 
significant cytokine response in vivo, however, no inducement of cytokine was 
observed in mice treated with 1 or [69Ga]Ga-1, even when they were administered at a 
dose 10 times higher than the effective PET-imaging dose. Data are shown as mean ± 
SEM. 
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Figure S7: Serum biochemistry analysis of mice treated with 1 and [69Ga]Ga-1 at 
different doses. 1×, 5× and 10× means the formulations were administered at the dose 
equal to the PET-imaging dose, 5 times the imaging dose and 10 times the imaging dose, 
respectively. Blood was withdrawn at 3.0 h and 24 h post administration. The major 
blood biochemistry parameters ALT (alanine transaminase), AST (aspartate 
transaminase), TBIL (Total Bilirubin), UREA, TP (total protein), ALP (alkaline 
phosphatase), TCHOL (total cholesterol) and TG (triacylglycerol) remained at the 
normal level, suggesting that both 1 and [69Ga]Ga-1 are safe in vivo, even when 
administered at a dose 10 times higher than the effective PET-imaging dose. Data are 
shown as mean ± SEM. 
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Figure S8: Histopathological analysis of main organs from mice treated with 1 and 
[69Ga]Ga-1 at three different doses: 1× the PET-imaging dose, 5× the imaging dose and 
10× the imaging dose. Tissue samples were collected at 24h post administration. No 
tissue sections revealed any significant histopathological change. Magnification, 200×.  
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Table S1 : Injected activities 
 n 
Injected doses (mean ± SD MBq) 
[18F]FDG  [68Ga]Ga-NOTA [68Ga]Ga-1  
Tumor model mice  3# 6.9 ± 0.2 6.4 ± 0.1 6.3 ± 1.1 
#for each tumor model. 
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General: The amine-terminated dendrimer 1a was synthesized according to the well-
established protocol published in our group [1-3]. NOTA and NODA-GA(tBu)3 was 
purchased from CheMatech (Dijon, France). Other chemicals were purchased from 
Acros Organics, Sigma Aldrich or Alfa Aesar. Methyl acrylate, ethylenediamine, 
trimethylamine, dichloromethane and methanol were dried according to the described 
methods and distilled before use. The other chemicals were used without further 
purification. Dialysis tubing was purchased from Sigma Aldrich (St. Quentin Fallavier, 
France). Analytical thin layer chromatography (TLC) was performed using silica gel 60 
F254 plates 0.2 mm thick with UV light (254 and 364 nm) as revelator. Radiolabeling 
analyses were performed on instant thin layer chromatography (iTLC) with a MiniGITA 
radiochromatography system (Elisia-Raytest, Angleur, Belgium). Chromatography was 
prepared on silica gel (Merck 200-300 mesh). IR spectra were recorded with an ALPHA 
FT-IR spectrometer (Bruker, France). 1H NMR spectra were recorded at 400 or 500 
MHz and 13C NMR spectra recorded at 100 MHz on Bruker Avance III 400, or JEOL 
ECS 400 spectrometers. Chemical shifts (δ) are expressed in parts per million (ppm) 
with the residual peak of CHCl3 at 7.26 ppm or CH3OH at 3.31 as internal reference. 
High resolution mass spectrometry experiments were performed with a Synapt G2 
HDMS quadrupole/time-of-flight (Manchester, UK) equipped with an electrospray 
source operating in positive mode. Samples were introduced at 10 µL/min flow rate 
(capillary voltage +2.8 kV, sampling cone voltage: varied between +20 V and +60 V) 
under a curtain gas (N2) flow of 100 L/h heated at 35 °C. Accurate mass experiments 
were performed using reference ions from CH3COONa internal or external standard. 
The samples were dissolved and further diluted in methanol (Sigma-Aldrich, St-Louis 
- MO, USA) doped with formic acid (1% v/v) prior to analysis. Data analyses were 
conducted using MassLynx 4.1 programs provided by Waters. 
 
Synthesis and characterization of the amphiphilic dendrimer 1 
To a solution of NODA-GA(tBu)3 (0.10 g, 0.18 mmol) in DMF (1.0 mL) were added 
PyBOP (96 mg, 0.18 mmol) and NMM (22 mg, 0.22 mmol). The mixture was stirred 
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for 5.0 min and then a solution of the amine-terminating dendrimer (12 mg, 12 µmol) 
in DMF (1.0 mL) was added and the resulting solution was stirred at 30oC for 3.0 days 
under argon. Thereafter, saturated NaHCO3 (15 mL) was added to the solution and ethyl 
acetate (3.0 × 10 mL) was used for extraction. The combined organic layers were 
collected, dried over anhydrous MgSO4, filtrated and evaporated under reduced 
pressure. The crude material was used without any purification for the next step. It was 
dissolved in a TFA/CH2Cl2 mixture (3.0 mL, v/v = 1/1) and stirred at 30 oC for 16 h 
under argon. After evaporating the solvent, the crude residue was purified by dialysis 
(dialysis tubing, MWCO 2000) and lyophilized. After repeating 4 times the operation 
of dialysis and lyophilization, the product was lyophilized to yield the corresponding 1 
as a white solid (24 mg, yield: 83%). 
1H NMR (500 MHz, D2O): δ 8.34 (s, 1H, -CH- triazole), 4.43 (s, 2H, -CH2-), 3.74-3.65 
(m, 22H, -CH2- + -CH-), 3.50-3.16 (m, 84H, -CH2-), 2.89 (s, 4H, -CH2-), 2.89 (s, 8H, -
CH2-), 2.41 (br, 8H, -CH2-), 2,09-1.99 (m, 8H, -CH2-), 1.88 (br, 2H, -CH2-), 1.23 (br, 
30H, -CH2-), 0.84-0.82 (m, 3H, -CH3); 13C NMR (100 MHz, D2O): δ176.5, 175.3, 173.4, 
172.4, 171.7, 135.8, 127.5, 66.3, 57.8, 51.3, 49.7, 47.2, 47.1, 47.0, 46.9, 46.7, 38.9, 38.5, 
36.5, 34.4, 34.3, 32.8, 32.0, 29.9, 29.5, 29.1, 28.8, 27.8, 26.4, 24.8, 22.7, 14.1. HRMS: 
calcd. for C111H197N28O343+ [M+3H]3+ m/z 822.4853, measured at m/z 822.4860. 
 
Synthesis and characterization of the amphiphilic dendrimer [69Ga]Ga-1  
To the solution of 1 (2.2 µmol, 1.0 mL) was added 90 µL of 2.0 M sodium acetate 
solution, followed by addition of the solution of 8.9 µmol of [69Ga]GaCl3 in 0.50 mL 
of 1.0 mM HCl. The resulting solution was incubated for 15 min at pH = 4.5 ~ 5.0 at 
20 - 25 °C. Then, the solution was subjected to dialysis against water (dialysis tubing, 
MWCO 2000) for 1 day, then lyophilized to give a white powder [69Ga]Ga-1 (4.7 mg, 
yield = 85% ). HRMS calcd. for C111H185N28O34Ga43+ m/z 911.3545, measured at m/z 
911.3547.  
 
Synthesis and characterization of [69Ga]Ga-NOTA  
The preparation of the Ga/NOTA complex followed the similar protocol as for 1. Briefly, 
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to 1.5 mL NOTA solution (33 µmol, milliQ water) was added 40 µL of 2.0 M sodium 
acetate solution, followed by the addition of [69Ga]GaCl3 (33 µmol, dissolved in 0.50 
mL of 1.0 mM HCl solution). The reaction mixture was incubated for 15 min at pH = 
4.5 ~ 5.0 at 20 - 25 °C. The obtained solution was dialyzed against water (dialysis tubing, 
MWCO 100) for 1.0 day, then lyophilized to give a white powder [69Ga]Ga-NOTA (9.9 
mg, yield = 81% ). HRMS calcd. for C12H19N3O6Ga+ m/z 370.0524, measured at m/z 
370.0522. 
 
High resolution mass spectrometry  
High resolution mass spectrometry experiments were performed with a Synapt G2 
HDMS quadrupole/time-of-flight (Manchester, UK) equipped with an electrospray 
source operating in positive mode. Samples were introduced at 10 µL/min flow rate 
(capillary voltage +2.8 kV, sampling cone voltage: varied between +20 V and +60 V) 
under a curtain gas (N2) flow of 100 L/h heated at 35 °C. Accurate mass experiments 
were performed using reference ions from CH3COONa internal standard. The samples 
were dissolved and further diluted in methanol (Sigma-Aldrich, St-Louis - MO, USA) 
doped with formic acid (1.0% v/v) prior to analysis. Data analyses were conducted 
using MassLynx 4.1 programs provided by Waters. 
 
Critical Micelle Concentration (CMC) measurement   
Critical micelle concentration (CMC) is a well-recognized parameter to evaluate the 
propensity of an amphiphile to form micellar structures by self-assembly in aqueous 
solution. Nile red was used as a fluorescence probe to measure CMC values of 
[69Ga]Ga-1. Solutions of [69Ga]Ga-1 at different concentrations from 2.0 × 10-7 to 1.0 
× 10-3 mol/L were prepared. The final Nile red concentration was 2.5 × 10-6 mol/L in 
the [69Ga]Ga-1 solutions. Then the solutions were sonicated for 10 min and kept for 2 
h at room temperature. Fluorescence spectra were recorded at the excitation wavelength 
of 550 nm on an F-4500 fluorescence spectrophotometer. The fluorescence intensity at 
635 nm was analyzed as a function of dendrimer concentration, and CMC values were 
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obtained accordingly. 
 
Dynamic light scattering (DLS) 
Dynamic light scattering (DLS) measurements were performed to determine the 
hydrodynamic diameter of the nanoparticles formed with the [69Ga]Ga-1 complex. 
[69Ga]Ga-1 was first dispersed in milliQ water at a concentration of 0.40 mg/mL, and 
sonicated 30 seconds at 60 Hz (Ultrasonic Cleaner Branson B-200), then the fresh 
solution was measured using a Malvern Zetasizer Nano ZS equipped with a standard 
633 nm laser at 25 °C. The experiments were done in triplicates. The experiments were 
done in triplicates. 
 
Transmission Electron Microscopy (TEM)  
Transmission electron microscopy (TEM) was performed using JEOL 3010 
transmission electron microscope (Tokyo, Japan) to characterize the size and 
morphology of the NPs at an accelerating voltage of 300 kV. [69Ga]Ga-1 was dispersed 
in milliQ water at a concentration of 0.40 mg/mL, and sonicated for 30 seconds, then 
diluted to 1.6 µg/mL, followed by depositing an aliquot (4.0 μL) onto a carbon-coated 
copper grid and dried at 37 °C. The grid was then stained with 3.0 μL uranyl acetate 
(2.0% in aqueous solution) for 4 seconds, and the excess uranyl acetate was removed 
by filter paper and dried at 37 °C for 60 minutes before measurements. 
 
Isothermal titration calorimetry (ITC) 
ITC experiments were performed with a MicroCal PEAQ-ITC calorimeter (Malvern, 
UK) at 25 °C. The cell volume was 208 μL. The binding thermodynamics of monomeric 
1 and Ga3+ was conducted as follow: a solution of 1 (15 μM in milliQ water ) was 
titrated with 19 step-by-step injections (2.0 μL each) of a 500 μM solution of GaCl3 in 
milliQ water. All solutions were degassed for 30 min at room temperature under stirring 
at 600 rpm prior to each experiment. After careful washing, the cell was pre-rinsed with 
a portion of milliQ water. Upon filling cell and syringe, stirring was turned on and the 
system was allowed to thermally equilibrate for 30 minutes. 
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Figure S3 shows the titration curve for chelation of Ga3+ with the dendrimer 1. Fitting 
the curve with a sigmoidal function (red line) yielded the information required to extract 
the corresponding binding thermodynamics parameters for [69Ga]Ga-1. Thus, the 
enthalpy change associated with the cation complexation (ΔH) was determined by 
subtracting the final (i.e., highest) plateau value from the initial (i.e., lowest) one. The 
chelation free energy (ΔG) was then calculated from the corresponding Ka, obtained as 
the slope of the sigmoidal curve at its inflection point via the fundamental 
thermodynamic relationship: ΔG = -RT lnKa. Kd was calculated as 1/Ka. Finally, the 
entropic variations upon binding were estimated using ΔG = ΔH – TΔS.  
 
Molecular modeling 
All simulations were carried out using AMBER 18 [4] on a CPU/GPU hybrid cluster. 
[69Ga]Ga-1 atom types were assigned via the Generalized Amber Force Field (GAFF) 
[5] and the Visual Force Field Derivation Toolkit (VFFDT) [6]. 100 [69Ga]Ga-1 
complexes were randomly placed in a simulation cubic box filled with TIP3 waters [7] 
and extending at least 2.0 nm from each solute molecule. System neutralization was 
achieved by adding the appropriate number of the chloride counterions. The hydrated 
system was subjected to an initial Steepest Descent (SD)/Conjugated Gradient (CG) 
minimization with 5.0 kcal/(molA2) restraint on the solute (solvent relaxation), 
followed by another round of CG minimization without restraints in order to eliminate 
all bad contacts between water molecules and each solute. Next, the minimized 
structure was subjected to molecular dynamics (MD) simulations in the canonical 
(NVT) ensemble under periodic boundary condition. During the 100 ps of MD, each 
system was gradually heated and relaxed to 25 °C. The SHAKE algorithm [8] was 
applied to all covalent bonds involving hydrogen atoms. An integration time step of 2.0 
fs was adopted together with the Langevin thermostat for temperature regulation 
(collision frequency = 5.0 ps-1) [9]. The final heating step was followed by 100 ns of 
MD equilibration in the isochoric/isothermal (NPT) ensemble. Pressure control was 
exerted by coupling the system to a Berendsen barostat (pressure relaxation time 2.0 ps) 
[8]. The Particle Mesh Ewald (PME) method [10] was used to treat long-range 
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electrostatic interactions under periodic conditions with a direct space cut-off of 10 Å. 
Finally, the NPT MD production run was performed for another 1.0 s. In this case, the 
Monte Carlo barostat implemented in Amber 18 was adopted for pressure control (1 
bar). 
 
Radiolabeling of [68Ga]Ga-1 
Ammonium acetate solution (0.10 mL of 2.0 M) was added to 50 µL dendrimer solution 
of 1 (1.0 µg/µL in milliQ water). To this solution was added [68Ga]GaCl3 solution (0.50 
mL) eluted from a 68Ge/68Ga generator (Galliapharm, Eckert&Ziegler, Berlin, 
Germany). The resulting solution was adjusted to pH = 7.0 and then vortexed and 
sonicated for 15 minutes at 60 Hz (Ultrasonic Cleaner Branson B-200) to promote the 
spontaneous self-assembly of [68Ga]Ga-1. The solution was used for in vitro and in vivo 
studies without further purification. The radiochemical purity of 92 ± 2.3% was 
determined by iTLC (solid phase: iTLC-SG paper purchased from Agilent (Les Ulis, 
France), mobile phase: 0.10 M sodium citrate pH = 5.0). 
 
Radiolabeling stability of [68Ga]Ga-1 
The radiolabeling stability of [68Ga]Ga-1 was assessed by incubating 0.10 mL of the 
radiotracer solution in 0.40 mL of 0.90 M sodium chloride solution or in 0.40 mL of 
human serum respectively. The radiochemical purity stability was checked by iTLC at 
room temperature right after the radiosynthesis and then at 37°C, 1.0 and 2.0 hours after 
the radiosynthesis.  
 
Octanol-water partition coefficient  
To an Eppendorf tube filled with 0.50 mL of the radiolabeled compound [68Ga]Ga-1, 
0.50 mL of octanol was added. The mixture was vigorously stirred by a vortex mixer 
for 2.0 min at room temperature, then both phases were separated by centrifugation 
(0.10 kg, 5.0 min). Three 0.10 mL samples were taken from each phase, and measured 
in a Canberra activimeter, then a mean log P was calculated. 
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Animals 
All procedures using animals were approved by the Institution’s Animal Care and Use 
Committee (CE14, Aix-Marseille University) and were conducted according to the EU 
Directive 2010/63/EU and the recommendations of the Helsinki Declaration. Six-week-
old BALB/c mice and athymic nude mice were purchased from Envigo. Animals were 
housed in enriched cages placed in a temperature- and hygrometry-controlled room 
with daily monitoring, fed with water and commercial diet ad libitum.  
 
Mice ectopic xenograft models of pancreatic, colon, prostate tumors and 
glioblastoma 
1.0 × 107 cells of trypsinized HT29 (human colon adenocarcinoma), 22Rv1 (human 
prostate cancer), U87 (human glioblastoma), SOJ-6 or L-IPC (primary pancreatic 
adenocarcinoma) cells were resuspended in 0.50 mL (PBS, Lonza, Basel, Switzerland) 
with 10% fetal calf serum. Each athymic nude mouse was subcutaneously injected with 
5.0 × 106 tumor cells/0.10 mL between the shoulders. Animals were then allowed for 
resting during 3.0 weeks.  
 
Mice orthotopic xenograft models of pancreatic tumors 
1.0 × 107 trypsinized SOJ-6 (primary pancreatic adenocarcinoma) cells were 
resuspended 0.25 mL Roswell Park Memorial Institute (RPMI) 1640 culture media 
(ThermoFisher Scientific, Waltham, USA) with 10% fetal calf serum and 0.25 mL 
Matrigel Matrix (Corning, New York, USA). Each athymic nude mouse was injected 
with 106 SOJ-6 cells/50 µL in the pancreas. Animals were allowed for resting during 
3.0 weeks. 
 
PET biodistribution and tumor uptake study 
For dynamic acquisitions, mice were injected in the caudal vein with [68Ga]Ga-1, 
[68Ga]Ga-NOTA, or [18F]FDG, and immediately imaged for a 2.0 h-dynamic µPET/CT 
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on a NanoScan PET/CT camera (Mediso, Budapest, Hungary) under 1.5% isoflurane 
anesthesia. The injected activities are summarized in Table S1. Each PET imaging 
session occurred at a 24 h-delay to prevent any background signal from one imaging 
session to another. Reconstruction and image treatment (InterView Fusion, Mediso) 
were carried out to assess tracer uptake in liver, heart, lungs, kidneys, bladder, brain, 
intestines and spleen, 5.0, 10, 20, 30, 60, 90 and 120 minutes after injection. Results 
were expressed as mean ± sd percentage of the injected dose (%ID). 
For static acquisitions, 20 min-PET images were acquired respectively 2.0 hours after 
injection of [68Ga]Ga-1, 1.0 hour after injection of [68Ga]Ga-NOTA, or 40 minutes after 
[18F]FDG injection, on a NanoScan PET/CT camera (Mediso) under 1.5% isoflurane 
anesthesia. Results were expressed as mean ± sd percentage of the injected dose per 
gram of tissue (%ID/g) and as mean±sd tumor-to-muscle ratio (%). 
 
Blood kinetics 
Mice were injected in the tail vein with [68Ga]Ga-1, [68Ga]Ga-NOTA, and [18F]FDG, 
respectively, under 1.5% isoflurane anesthesia. The injected activities are summarized 
in Table S1. 10 µL-blood sampling was carried out from the jugular vein at 5.0, 10, 20, 
30, 60, and 90 minutes after injection. Samples were then diluted up to 1.0 mL with 
PBS and counted on a Packard Cobra-II 5002 gamma-counter. Results were decay-
corrected, expressed as mean ± sd percentage of the injected dose per gram of tissue 
(%ID/g). 
 
Tumor blood flow measurement 
SOJ-6 orthotopic tumor blood flow was assessed by live 3D-Doppler on a Vevo2100 
High Resolution ultrasound system (Visualsonics, Toronto, Canada) with the MS-550D 
probe (22-55 MHz, axial resolution 40 µm, Visualsonics), by an experienced operator, 
on 2 time points at a 1-week interval, 3 weeks after xenograft, and 1 hour before 
[68Ga]Ga-1 PET acquisition. Mice were anesthetized using isoflurane 1.5%, secured on 
a heated animal handling platform enabling electrocardiography, respiration, and 
temperature monitoring. Ultrasound gel (Aquasonic 100; Parker Laboratories, Fairfield, 
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NJ, USA) was used as coupling interface between the ultrasound probe and the animal. 
Tumor blood flow turbulence was measured in a 75 ± 5.0% area from the tumor borders 
in order to avoid any neighboring vessel likely to interfere with the results. 
 
In vivo toxicity 
Animals were maintained in Peking University Laboratory Animal Center (an 
AAALAC-accredited experimental animal facility). All procedures involving 
experimental animals were performed in accordance with protocols approved by the 
Institutional Animal Care and Use Committee of Peking University. Male CD-1 mice 6 
- 8 weeks old, weighing 32-38 g, were purchased from Beijing Vital River Laboratory 
Animal Technology Co., Ltd. Solutions of the dendrimer 1 and the [69Ga]Ga-1 complex 
were systemically administered into mice via tail vein injection (3 animals per group) 
at three different doses (1× the imaging dose, 5× the imaging dose, and 10 × the imaging 
dose). Buffer solution and lipopolysaccharide (LPS) were included as control (6 
animals). Blood samples were collected and serum specimens were prepared at 3.0 h 
and 24 h post-administration. A part of serum specimens were sent to Beijing DIAN 
Clinical Laboratory Co. Ltd., Beijing, China (a subsidiary of Zhejiang DIAN 
Diagnostics Co., Ltd. China). Concentrations of ALT (alanine transaminase), AST 
(aspartate transaminase), TBIL (Total Bilirubin), UREA, TP (total protein), ALP 
(alkaline phosphatase), TG (triacylglycerol) and TCHOL (total cholesterol) in serum 
were detected with a biochemistry analyzer. Meanwhile, the levels of several cytokines, 
including TNF-α (tumor necrosis factor alpha), IFN-γ (interferon gamma), IL-6 
(interleukin 6), KC (keratinocyte-derived cytokine, or CXCL1, chemokine (C-X-C 
motif) ligand 1), MCP-1 (monocyte chemoattractant protein-1, or CCL2, chemokine 
(C-C motif) ligand 2), GM-CSF (granulocyte-macrophage colony-stimulating factor 
(GM-CSF), or CSF2, colony stimulating factor 2), IL-1 (interleukin 1) and IL-5 
(interleukin 5) were measured with immunoassays based on Luminex xMAP (multi-
analyte profiling) technology (Beijing 4A Biotech Co., Ltd) according to the 
manufacturer’s protocol. The main organs were also collected at 24 h post-
administration, kept and fixed in 10% formalin, paraffin embedded, sectioned and 
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stained with H&E, and then observed under an optical microscope for histological 
changes. 
 
Statistics 
Radiochemical purities were compared with 2-way ANOVA followed by a post-hoc 
Bonferroni test. For each xenografted tumor model, tumor uptakes and tumor-to-muscle 
ratios were compared with a Wilcoxon matched-pairs signed rank test. Pearson 
correlation was assessed between PET signal quantification in SOJ-6 orthotopic tumors 
and the 3D-Doppler-enabled tumor blood flow measurements. Statistical analyses were 
performed with Prism® software (GraphPad Software). P < 0.05 indicated statistical 
significance. 
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